Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.

Kawasaki disease (KD) is the most common cause of multisystem vasculitis in childhood. Although cervical lymphadenitis is one of the major symptoms in KD, lymph node biopsy is rarely performed, because KD is usually diagnosed by clinical symptoms. A cervical lymph node biopsy was taken from a girl aged 1 year and 8 months who had suspected lymphoma, but she was diagnosed with KD after the biopsy. The cervical lymph node specimen was analyzed with multivirus real-time PCR that can detect >160 viruses, and unbiased direct sequencing with a next-generation DNA sequencer to detect potential pathogens in the lymph node. Histologically, focal necrosis with inflammatory cell infiltration, including neutrophils and macrophages, was observed in the marginal zone of the cervical lymph node, which was compatible with the acute phase of KD. Multivirus real-time PCR detected a low copy number of torque teno virus in the sample. Comprehensive direct sequencing of the cervical lymph node biopsy sample sequenced more than 8 million and 3 million reads from DNA and RNA samples, respectively. Bacterial genomes were detected in 0.03% and 1.79% of all reads in DNA and RNA samples, respectively. Although many reads corresponded to genomes of bacterial environmental microorganisms, Streptococcus spp. genome was detected in both DNA (77 reads) and RNA (2,925 reads) samples. Further studies are required to reveal any association of microbial or viral infection with the pathogenesis of KD.

[1]  T. Sata,et al.  A novel real‐time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses , 2010, Journal of medical virology.

[2]  Nicholas J Loman,et al.  High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. , 2010, Current opinion in microbiology.

[3]  R. Yeung Kawasaki disease: update on pathogenesis , 2010, Current opinion in rheumatology.

[4]  Yusuke Nakamura,et al.  Common variants in CASP3 confer susceptibility to Kawasaki disease. , 2010, Human molecular genetics.

[5]  K. Kotani,et al.  Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2007–2008 Nationwide Survey , 2010, Journal of epidemiology.

[6]  S. Israels,et al.  Mechanisms of oral bacteria-induced platelet activation. , 2010, Canadian journal of physiology and pharmacology.

[7]  Masato Tashiro,et al.  Characterization of Quasispecies of Pandemic 2009 Influenza A Virus (A/H1N1/2009) by De Novo Sequencing Using a Next-Generation DNA Sequencer , 2010, PloS one.

[8]  Teruyo Ito,et al.  Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease , 2009, Immunology.

[9]  Forest Rohwer,et al.  Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals , 2009, PloS one.

[10]  S. Hammerschmidt,et al.  Pneumococcal association to platelets is mediated by soluble fibrin and supported by thrombospondin-1 , 2009, Thrombosis and Haemostasis.

[11]  N. Yoshikawa,et al.  Detection of multiple superantigen genes in stools of patients with Kawasaki disease. , 2009, The Journal of pediatrics.

[12]  K. Durongpisitkul,et al.  Clinical manifestations of Kawasaki disease: what are the significant parameters? , 2009, Asian Pacific journal of allergy and immunology.

[13]  J. Kawai,et al.  Direct Metagenomic Detection of Viral Pathogens in Nasal and Fecal Specimens Using an Unbiased High-Throughput Sequencing Approach , 2009, PloS one.

[14]  E. Charpentier,et al.  Lysogenic transfer of group A Streptococcus superantigen gene among Streptococci. , 2008, The Journal of infectious diseases.

[15]  T. Fukaya,et al.  The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease , 2007, Current opinion in infectious diseases.

[16]  Alexander F. Auch,et al.  MEGAN analysis of metagenomic data. , 2007, Genome research.

[17]  J. Petrik,et al.  Progression towards AIDS leads to increased torque teno virus and torque teno minivirus titers in tissues of HIV infected individuals , 2007, Journal of medical virology.

[18]  R. Yeung,et al.  TNF-α Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease1 , 2006, The Journal of Immunology.

[19]  Walter R Wilson,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Pediatrics.

[20]  N. Ohno Murine model of Kawasaki disease induced by mannoprotein-beta-glucan complex, CAWS, obtained from Candida albicans. , 2004, Japanese journal of infectious diseases.

[21]  Kazuo Suzuki,et al.  Induction of Coronary Arteritis with Administration of CAWS (Candida albicans Water‐Soluble Fraction) Depending on Mouse Strains , 2004, Immunopharmacology and immunotoxicology.

[22]  W. Yeo,et al.  Gross Elevation of TT Virus Genome Load in the Peripheral Blood Mononuclear Cells of Cancer Patients , 2001, Annals of the New York Academy of Sciences.

[23]  K. Katayama,et al.  Changes of DNA titer and sequence variance of TT virus in hepatic disorders. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

[24]  T. Sata,et al.  Progressive outer retinal necrosis caused by herpes simplex virus type 1 in a patient with acquired immunodeficiency syndrome. , 2000, Ophthalmology.

[25]  N. Horiike,et al.  Existence of TT Virus DNA in Extracellular Body Fluids from Normal Healthy Japanese Subjects , 2000, Intervirology.

[26]  S. Mori,et al.  High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. , 1999, The American journal of pathology.

[27]  Y. Liaw,et al.  High Prevalence of TT Virus Infection in Healthy Children and Adults and in Patients with Liver Disease in Taiwan , 1999, Journal of Clinical Microbiology.

[28]  Mark George Thomas,et al.  Presence of a newly described human DNA virus (TTV) in patients with liver disease , 1998, The Lancet.

[29]  T. Nishizawa,et al.  A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. , 1997, Biochemical and biophysical research communications.

[30]  K. Waki,et al.  A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection , 1997, Acta paediatrica.

[31]  Y. Ito,et al.  Clinical role for a superantigen in Yersinia pseudotuberculosis infection. , 1997, The Journal of clinical investigation.

[32]  S. Shulman,et al.  Seven‐year national survey of Kawasaki disease and acute rheumatic fever , 1994, The Pediatric infectious disease journal.

[33]  T. Ezaki,et al.  Biologically active extracellular products of oral viridans streptococci and the aetiology of Kawasaki disease. , 1993, Journal of medical microbiology.

[34]  M. Herzberg,et al.  The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain. , 1993, The Journal of biological chemistry.

[35]  T. Sata,et al.  Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti‐HPV monoclonal antibody , 1992, The Journal of pathology.

[36]  S. Matsumoto,et al.  Kawasaki Disease and Epstein‐Barr Virus , 1991, Lancet.

[37]  C. Benoist,et al.  Superantigens interact with MHC class II molecules outside of the antigen groove , 1990, Cell.

[38]  P. Marrack,et al.  Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens , 1990, Nature.

[39]  P. Marrack,et al.  V beta-specific stimulation of human T cells by staphylococcal toxins. , 1989, Science.

[40]  J. Fraser High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR , 1989, Nature.

[41]  Philippa Marrack,et al.  The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice , 1989, Cell.

[42]  J. Steitz,et al.  Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Krause,et al.  Lymph node biopsy for early diagnosis in Kawasaki disease , 1982, The American journal of surgical pathology.

[44]  M. Bergdoll,et al.  A NEW STAPHYLOCOCCAL ENTEROTOXIN, ENTEROTOXIN F, ASSOCIATED WITH TOXIC-SHOCK-SYNDROME STAPHYLOCOCCUS AUREUS ISOLATES , 1981, The Lancet.

[45]  T. Kawasaki,et al.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].

[46]  Hong Qiang,et al.  Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis , 2010, Journal of clinical laboratory analysis.

[47]  中村 常之 Vasculitis induced by immunization with bacillus Calmette-Guerin followed by atypical mycobacterium antigen : a new mouse model for Kawasaki disease , 2007 .

[48]  T. Sata,et al.  Immunohistochemical study of skin lesions in herpes zoster , 2005, Virchows Archiv A.

[49]  T. Sata,et al.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases , 2004, Virchows Archiv.

[50]  E. Silverman,et al.  Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. , 2003, International immunology.

[51]  K. Pfizenmaier,et al.  N-glycosidase treatment of Colo 205 cells interferes with hIFN-gamma induced HLA-DR expression. , 1989, Lymphokine research.